Gastrointestinal satiety signals

被引:120
作者
Chaudhri, Owais B. [1 ]
Salem, Victoria [1 ]
Murphy, Kevin G. [1 ]
Bloom, Stephen R. [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll London, Dept Metab Med, London W12 0NN, England
基金
英国医学研究理事会;
关键词
pancreatic polypeptide; peptide YY; glucagon-like peptide-1; oxyntomodulin; cholecystokinin; vagus nerve;
D O I
10.1146/annurev.physiol.70.113006.100506
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The increasing prevalence of obesity worldwide has imparted renewed impetus to the study of the mechanisms of appetite regulation. Digestion and nutrient absorption take place in the gastrointestinal (GI) tract, whereas food intake is controlled by neuronal circuits in the central nervous system. The need for gut-brain cross talk is therefore clear. It is now recognized that hormones released into the circulation from the GI tract in response to nutritional stimuli form a key component of this gut-brain axis. Peptides such as glucagon-like peptide-1, oxyntomodulin, pancreatic polypeptide, and peptide YY3-36 reduce food intake in both animal models and in humans. Physiologically, such peptides are thought to act as satiety signals and meal terminators. Here, we review the current state of the field of the effects of gut hormone action on appetite control.
引用
收藏
页码:239 / 255
页数:17
相关论文
共 118 条
[61]  
KIRN MS, 2000, DIABETES, V49, P177
[62]   C-TERMINAL OCTAPEPTIDE OF CHOLECYSTOKININ DECREASES FOOD-INTAKE IN MAN [J].
KISSILEFF, HR ;
PISUNYER, FX ;
THORNTON, J ;
SMITH, GP .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (02) :154-160
[63]   The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats [J].
Koda, S ;
Date, Y ;
Murakami, N ;
Shimbara, T ;
Hanada, T ;
Toshinai, K ;
Niijima, A ;
Furuya, M ;
Inomata, N ;
Osuye, K ;
Nakazato, M .
ENDOCRINOLOGY, 2005, 146 (05) :2369-2375
[64]   The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight [J].
Kopin, AS ;
Mathes, WF ;
McBride, EW ;
Nguyen, M ;
Al-Haider, W ;
Schmitz, F ;
Bonner-Weir, S ;
Kanarek, R ;
Beinborn, M .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :383-391
[65]   VASOACTIVE INTESTINAL PEPTIDE - BEHAVIORAL-EFFECTS IN THE RAT AND HAMSTER [J].
KULKOSKY, PJ ;
DOYLE, JS ;
COOK, VI ;
GLAZNER, GW ;
FODERARO, MA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (02) :387-393
[66]   The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: Differential effects in rats and mice [J].
Lachey, JL ;
D'Alessio, DA ;
Rinaman, L ;
Elmquist, JK ;
Drucker, DJ ;
Seeley, RJ .
ENDOCRINOLOGY, 2005, 146 (01) :458-462
[67]   The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex [J].
Larsen, PJ ;
Kristensen, P .
MOLECULAR BRAIN RESEARCH, 1997, 48 (01) :1-6
[68]   LOW PLASMA-LEVELS OF PANCREATIC-POLYPEPTIDE IN OBESITY [J].
LASSMANN, V ;
VAGUE, P ;
VIALETTES, B ;
SIMON, MC .
DIABETES, 1980, 29 (06) :428-430
[69]   CHOLECYSTOKININ BIOACTIVITY IN HUMAN-PLASMA - MOLECULAR-FORMS, RESPONSES TO FEEDING, AND RELATIONSHIP TO GALLBLADDER CONTRACTION [J].
LIDDLE, RA ;
GOLDFINE, ID ;
ROSEN, MS ;
TAPLITZ, RA ;
WILLIAMS, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) :1144-1152
[70]   REDUCTION OF FOOD-INTAKE IN RATS BY INTRAPERITONEAL INJECTION OF LOW-DOSES OF AMYLIN [J].
LUTZ, TA ;
DELPRETE, E ;
SCHARRER, E .
PHYSIOLOGY & BEHAVIOR, 1994, 55 (05) :891-895